OR WAIT null SECS
March 02, 2010
Pre-Interphex 2010 Product Releases.
In Part I of this article, the authors describe the materials and methods used in developing a screening strategy to accelerate the preparation and characterization of spherical agglomerates by spherical crystallization.
To best carry out the vision of Hatch-Waxman, Congress must act now on biogenerics.
From last-minute product inserts to putting out fires, close calls are a common occurrence.
If both sides of the aisle don't agree on even mild healthcare reform soon, the bill could die out.
March 01, 2010
Although efforts have been made to improve solubility, many poorly soluble drugs still reach the market. Peter Nielsen discusses new developments in solubilisation technology, which could help those companies seeking to reinvigorate marketed products.
The second annual Pharmaceutical Technology Bioprocessing Survey offers a snapshot of the industry following 2009's megamergers.
A new kind of gastro-retentive dosage form for drugs with poor aqueous solubility was developed and evaluated, with the aim of achieving gastro-retention.
February 25, 2010
Merck To Eliminate 15,000 jobs; Tauzin Stepping Down At PhRMA; And More.
February 18, 2010
Abbott Completes Acquisition Of Solvay; Merck Names President of Consumer Healthcare; And More.